Barclays PLC Solid Biosciences Inc. Call Options Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2019

Feb 10, 2020
SELL
$2.82 - $12.9 $328,248 - $1.5 Million
-116,400 Reduced 92.09%
10,000 $45,000
Q3 2019

Nov 14, 2019
SELL
$4.33 - $11.64 $368,050 - $989,400
-85,000 Reduced 40.21%
126,400 $1.31 Million
Q2 2019

Aug 14, 2019
BUY
$4.6 - $10.13 $972,439 - $2.14 Million
211,400 New
211,400 $1.22 Million

Others Institutions Holding SLDB

# of Institutions
2
Shares Held
97
Call Options Held
0
Put Options Held
0
View Full List

About Solid Biosciences Inc.

SLDB Quotes by TradingView
  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $30.4M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email